Skip to main content
. 2019 Oct 17;22(5):665–674. doi: 10.1093/neuonc/noz191

Table 3.

Internal 10-fold cross-validation concordance indices (95% CI) for CPH, RSFs, and RPA at 60, 90, and 120 months for patients newly diagnosed with LGG (TCGA training set)

CPH RSF RPA
60 mo 0.844
(0.785–0.902)
0.806
(0.750–0.863)
0.792
(0.726–0.858)
90 mo 0.843
(0.786–0.900)
0.791
(0.725–0.857)
0.792
(0.726–0.858)
120 mo 0.841
(0.783–0.900)
0.782
(0.715–0.850)
0.792
(0.726–0.858)